| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (1840 + penicillin-resistant) |
- |
- |
6.25 － ? |
SCE-129  |
616 |
| Staphylococcus aureus (1840 + penicillin-resistant) |
- |
- |
12.5 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (1840) |
- |
- |
12.5 － ? |
FNQ13 |
257 |
| Staphylococcus aureus (18417 + methicillin-resistant) |
- |
- |
? － 0.8 |
Gentamicin (Gentamycin, Garamycin) |
68 |
| Staphylococcus aureus (18417 + methicillin-resistant) |
- |
- |
? － 0.8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
68 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
0.25 － ? |
Dalbavancin |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
0.5 － ? |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
0.5 － ? |
Oritavancin (LY333328) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
0.5 － ? |
Oritavancin (LY333328) |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Daptomycin (Cubicin) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Daptomycin (Cubicin) |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Quinupristin/Dalfopristin (Synercid) |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
2 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
4 － ? |
Gatifloxacin (Tequin) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
4 － ? |
Ranbezolid (RBX 7644) |
72 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
4 － ? |
Ranbezolid (RBX 7644) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
16 － ? |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococcus aureus (19 + methicillin-resistant) |
- |
- |
32 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococcus aureus (1-909) |
- |
- |
16 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
264 |
| Staphylococcus aureus (1998) |
0.25 |
32 |
≤0.06 － 64 |
Meropenem (Merrem) |
907 |
| Staphylococcus aureus (1998) |
0.5 |
2 |
≤0.06 － 2 |
Tigecycline (GAR-936, Tigacyl) |
907 |